Project Grant 2414793
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$429K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Austin, TX 78712, USA
Similar Awards
This $544,475 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) aims to develop an in vitro cancer metastasis model system using decellularized organ-specific tissue (biomatrices) to study organ-specific cancer metastasis. The University of Texas Southwestern Medical Center, the awardee, hypothesizes that the biomatrices can recapitulate the organ microenvironment and enable the growth of organ-specific tumor colonies, which can be used to investigate...
This National Science Foundation Project Grant of $299,785 will fund research into the integrated effects of mechanical and biochemical factors on breast tumor invasion and metastasis. Awarded on September 1, 2022 under the Engineering program (CFDA 47.041), the grant supports a collaborative research project led by the University of Michigan from September 1, 2022 through August 31, 2025. Specifically, the research team will develop quantitative imaging biosensors and tissue-engineered breast...
This $487,795 award from the National Science Foundation (NSF) Engineering grant program (CFDA 47.041) supports Arizona State University in developing innovative ex vivo models of the tumor microenvironment (TME). The project aims to mechanistically understand how biophysical cues and signaling between stromal and immune cells contribute to the transition of tumor cells into an invasive phenotype, as well as explore how stromal cell function induces pathway signatures in tumor cells leading to...
This National Science Foundation (NSF) Engineering program (CFDA 47.041) Project Grant award of $575,000 to the New Jersey Institute of Technology (NJIT) will study how the microstructure and interstitial fluid pressure gradient impact cell invasion in a bioprinted tumor-on-a-chip model. The key products and services to be delivered include: Developing a 3D bioprinted tumor spheroid microtissue model with controlled microstructure and tunable fluid-induced pressure. This will involve...
This Project Grant award of $360,000.00 from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop a biomimetic three-dimensional engineered model incorporating innate immune cells, such as macrophages and microglia, to study drug resistance in brain metastatic breast cancer (BMBC). The goal is to use this model to elucidate how microglia and macrophages, as well as their polarization state, influence BMBC cell phenotype and therapy response. The project will be...
This Project Grant award, with a total funding amount of $265,151.00, was provided by the National Science Foundation's (NSF) Engineering program (CFDA 47.041) to the University of Southern California. The project aims to use mathematical modeling and experiments to understand what regulates leakiness in the lymphatic system, with the goal of developing strategies to modulate lymphatic permeability. The research will investigate how lipids regulate CD36, a long-chain fatty acid translocase,...
This $333,567 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) will fund a collaborative research effort at Saint Louis University to determine the role of lipids in regulating lymphatic permeability. The project aims to develop an integrated computational and experimental approach to understand how lipids and the CD36 translocase regulate lymphatic vessel integrity and cell signaling. Researchers will use a systems biology methodology...
This National Science Foundation (NSF) Engineering Program (CFDA 47.041) award of $470,955 to Cornell University aims to develop a microfluidic cell culture platform to study breast cancer-associated secondary lymphedema. The 5-year project seeks to comprehend the regulation of lymphatic structure and function in breast cancer, and discover new treatment approaches for the over 150 million lymphedema patients worldwide. The research involves creating engineered lymphatic vessel models to analyze...
This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $629,998 to Worcester Polytechnic Institute to develop in vitro models for investigating the biophysical and biochemical drivers of fibrosis progression and regression across diverse engineered platforms. The project aims to create models for pancreatic, skin, and uterine fibroid fibrosis to advance understanding of how tissue-specific extracellular matrix features, cellular composition,...
This National Science Foundation Project Grant of $606,649 will support the development of an engineered cyber-physical system combining advanced biological models and artificial intelligence methods to enable precision medicine for cancer treatment. Awarded under the Computer and Information Science and Engineering program, the funding will be used by Brigham and Women's Hospital and its parent organization Partners Healthcare System from October 2022 to September 2025. Specifically, the...